Multiple Sclerosis research trust launches in NZ
July 1, 2015The New Zealand Multiple Sclerosis Research Trust (“NZMSRT”) today announces it has received a combined $900,000 investment portfolio as founding capital for the Trust.read more
All News
NZMSRT Trustee nominated for Pride of NZ award
June 29, 2015Neil Woodhams had no experience of the incurable neurological disease multiple sclerosis (MS) until his wife Erin was diagnosed with it in 1994. There was little reliable information, limited drugs…read more
Predicting risk of disability
June 24, 2015Two articles published recently by Australian and international investigators using the MSBase database provide insight into several factors that most strongly predict the risk of accumulating MS-related disability.read more
Placental stem cells reduce disease in a laboratory model of MS
June 24, 2015An Australian research team led by Professor Claude Bernard and Dr Natalie Payne, working with colleagues at the Australian Regenerative Medicine Institute at Monash University in Victoria, have been investigating…read more
Two new studies identify genetic changes linked to specific symptoms of MS
June 23, 2015Over the last few years, genetic studies that included thousands of people with MS from around the world have identified a large number of genetic changes that may increase a…read more
NZ Incidence Study
June 21, 2015Incidence studies are a well validated tool to better elucidate the cause and risk factors of a disease and plan effective preventive and management strategies. New Zealand (NZ) is ideally…read more
Case of PML
June 12, 2015The pharmaceutical sponsor of Gilenya (fingolimod), Novartis, has this week reported one case of Progressive Multifocal Leukoencephalopathy (PML) in an individual currently being treated with Gilenya in Europeread more
US researchers discover new structures linking the brain and the immune system
June 11, 2015Researchers from the University of Virginia in the USA recently discovered a new structure linking the central nervous system and the immune system that had previously been unreported in the…read more
A shorter treatment gap is better when switching from natalizumab (Tysabri) to fingolimod (Gilenya)
June 9, 2015A shorter treatment gap is better when switching from natalizumab (Tysabri) to fingolimod (Gilenya)read more
MS Research Australia June Newsletter
June 2, 2015MS Research Australia produces a monthly newsletter....read more